Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition" or the "Company"), a commercial-stage biopharmaceutical company ...

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal ...

In the present study, in part 1 (fasting condition trial), the 90% CIs of both the mean AUC 0-12 and C max ratios lay within the acceptance range of 0.80, 1.25.

VANCOUVER, BC/ ACCESS Newswire/ April 23, 2025/ BioNxt Solutions Inc., a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its ...

HealthDay News — The US Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted ...

BioNxt Solutions Prepares for Human Bioequivalence Study For MS Provided by Accesswire Apr 23, 2025 7:05am. VANCOUVER, BC / ACCESS Newswire / April 23, ...